methylprednisolone hemisuccinate has been researched along with Acute Relapsing Multiple Sclerosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dinh, A; Donzé, C; Hautecoeur, P; Heinzlef, O | 1 |
Chan, SC; Dmitrovic, J; Metz, LM; Morrow, SA; Stoian, CA | 1 |
Dastidar, P; Elovaara, I; Lehtimäki, T; Leppäkynnäs, M; Luomala, M; Peltola, J; Ukkonen, M | 1 |
2 trial(s) available for methylprednisolone hemisuccinate and Acute Relapsing Multiple Sclerosis
Article | Year |
---|---|
The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Area Under Curve; Biological Availability; Biotransformation; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Liver; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Prednisolone; Prednisone | 2004 |
Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy.
Topics: Adult; Atrophy; Brain; Cell Adhesion Molecules; E-Selectin; Enzyme-Linked Immunosorbent Assay; Female; Gadolinium; Humans; Immunohistochemistry; Inflammation; Injections, Intravenous; Integrin alpha4beta1; Integrins; Intercellular Adhesion Molecule-1; Lymphocyte Function-Associated Antigen-1; Lymphocytes; Magnetic Resonance Imaging; Male; Methylprednisolone Hemisuccinate; Middle Aged; Monocytes; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Predictive Value of Tests; Receptors, Lymphocyte Homing; Vascular Cell Adhesion Molecule-1 | 2000 |
1 other study(ies) available for methylprednisolone hemisuccinate and Acute Relapsing Multiple Sclerosis
Article | Year |
---|---|
[To treat or not to treat asymptomatic bacteriuria before methylprednisolone perfusion].
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Asymptomatic Diseases; Bacteriuria; Disease Progression; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Methylprednisolone Hemisuccinate; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Treatment Outcome; Unnecessary Procedures; Urinary Tract Infections | 2015 |